Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Jiang, Hao  [Clear All Filters]
2013
Wang J, Huang XJun, Jiang B, Jiang Q, Lu XJing, Xu LPing, Liu DHong, Chen H, Bao L, Lu J, et al. [Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia]. Beijing Da Xue Xue Bao. 2013;45(6):938-44.
2016
Yu J-B, Jiang H, Zhan R-Y. Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion. Mol Med Rep. 2016.
2018
Qin Y-Z, Jiang Q, Jiang H, Lai Y-Y, Shi H-X, Chen W-M, Yu L, Huang X-J. Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre. Br J Haematol. 2018.
Wang Y-Z, Hao L, Chang Y, Jiang Q, Jiang H, Zhang L-P, He L-L, Yuan X-Y, Qin Y-Z, Huang X-J, et al. A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype. Leuk Res. 2018;72:12-19.
2020
Jiang H. The complex activities of the SET1/MLL complex core subunits in development and disease. Biochim Biophys Acta Gene Regul Mech. 2020:194560.
Zhang J-M, Xu Y, Gale RP, Wu L-X, Zhang J, Feng Y-H, Qin Y-Z, Jiang H, Jiang Q, Jiang B, et al. DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia. Br J Haematol. 2020.
Zhao X-Y, Jiang Q, Jiang H, Hu L-J, Zhao T, Yu X-X, Huang X-J. Expanded clinical-grade membrane-bound IL-21/4-1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo. Eur J Immunol. 2020.
Wu Y-J, Hou M, Liu H-X, Peng J, Ma L-M, Yang L-H, Feng R, Liu H, Liu Y, Feng J, et al. A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data. Blood Adv. 2020;4(22):5846-5857.
Zhao P, Hou M, Liu Y, Liu H-X, Bin Huang R-, Yao H-X, Niu T, Peng J, Jiang M, Han Y-Q, et al. Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age. Platelets. 2020:1-9.
2021
Brenes AJ, Yoshikawa H, Bensaddek D, Mirauta B, Seaton D, Hukelmann JL, Jiang H, Stegle O, Lamond AI. Erosion of human X chromosome inactivation causes major remodeling of the iPSC proteome. Cell Rep. 2021;35(4):109032.
2022
Li S, Jiang H, Xing W, Wang S, Zhang Y, Li Y, Mao C, Zeng D, Lan P, Tang D, et al. A Clinical Diagnostic Study: Fibulin-2 is a Novel Promising Biomarker for Predicting Infection. Infect Dis Ther. 2022.
Wang J, Jiang H, Jing Y, Su L, Liu D, Zhou D, Wang J, Liu H, Ruan GRui, Gao S, et al. Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA. Br J Haematol. 2022.
2023
Li Y, Wang Y, Wang Z, Feng L, Gao L, Shi Y, Dang H, He Q, Qin Y, Jiang Q, et al. [Analysis of the characteristics of primary acute myeloid leukemia with 11q23/KMT2A rearrangements in ninety patients]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2023;40(12):1472-1477.
Sun Y-Q, Zhang X-H, Jiang Q, Jiang H, Chang Y-J, Wang Y, Xu L-P, Liu K-Y, Huang X-J. Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia. Bone Marrow Transplant. 2023.
Zhu X, Jiang Q, Lu J, Sun Y, Zhao X, Yang S, Tang F, Yu W, Zhao T, Liu X, et al. COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China. Br J Haematol. 2023.
Cao L-M, Zhou Y-L, Gale RPeter, Qin Y-Z, Wu L-X, Zhao M-Y, Zhao X-S, Chen Y-H, Wang Y, Jiang H, et al. CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia. Biomol Biomed. 2023.
Tang F, Zhao X, Ruan G, Jiang Q, Jiang H, Xu L, Wang Y, Zhang X, Liu K, Huang X. The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutation. Hematol Oncol. 2023.
Ma L, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia. Front Oncol. 2023;13:1166990.
Li S-D, Xing W, Wang S-C, Bin Li Y-, Jiang H, Zheng H-X, Li X-M, Yang J, Bin Guo D-, Xie X-Y, et al. Fibulin2: a negative regulator of BMSC osteogenic differentiation in infected bone fracture healing. Exp Mol Med. 2023.
An Z-Y, Wu Y-J, Hou Y, Mei H, Nong W-X, Li W-Q, Zhou H, Feng R, Shen J-P, Peng J, et al. A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study. Sci Bull (Beijing). 2023.
Zhou Y-L, Zhao M-Y, Gale RPeter, Jiang H, Jiang Q, Liu L-X, Qin J-Y, Cao S-B, Lou F, Xu L-P, et al. Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics. Leukemia. 2023.
Ahn BY, Kang M, Jeon H, Kim J-S, Jiang H, Ha J, Park C. Origin and population structure of native dog breeds in the Korean peninsula and East Asia. iScience. 2023;26(6):106982.
Zhang Q, Deng K, Liu M, Yang S, Xu W, Feng T, Jie M, Liu Z, Sheng X, Chen H, et al. Phase separation of BuGZ regulates gut regeneration and aging through interaction with mA regulators. Nat Commun. 2023;14(1):6700.
Wu P-H, Huo W-X, Mo X-D, Wang Y, Yan C-H, Jiang H, Shen M-Z, Huang X-J, An Y-Z. Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor. Ann Hematol. 2023.
Pan X'an, Chang Y, Ruan G, Wei F, Jiang H, Jiang Q, Huang X, Zhao X. Prognostic impact of FLT3-ITD mutation on NPM1 acute myeloid leukaemia patients and related molecular mechanisms. Br J Haematol. 2023.

Pages